GlassScriptPhysician profile
Peter J Francis
NPI 1851484406
$1,136.86
in general payments reported to CMS, 2019-2025
23 companies · $92.78 in 2025
The $92.78 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $104 · 2021: $175 · 2022: $169 · 2023: $205 · 2024: $227 · 2025: $92.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $210.63 | 2019-2024 | Vaxneuvance, Gardasil 9, Vaxelis |
| Glaxosmithkline, LLC. | $153.00 | 2019-2024 | Bexsero, Pediarix |
| Tris Pharma INC | $110.53 | 2019-2024 | Dyanavel Xr |
| Supernus Pharmaceuticals, INC. | $85.29 | 2021-2025 | Qelbree, Qelbree |
| Kaleo, INC. | $64.37 | 2019-2023 | Auvi-Q |
| Biomarin Pharmaceutical INC. | $61.24 | 2021-2024 | Voxzogo 1.2mg |
| Takeda Pharmaceuticals U.S.A., INC. | $52.53 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $44.17 | 2024-2025 | |
| Alk-Abello, INC | $35.98 | 2023-2024 | Odactra, Ragwitek, Grastek |
| Adlon Therapeutics L.P. | $31.20 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $30.02 | 2024 | Flumist Quadrivalent |
| Seqirus USA INC | $29.61 | 2022 | |
| Ironshore Pharmaceuticals INC. | $29.17 | 2019 | |
| Pfizer INC. | $27.39 | 2023 | |
| Ars Pharmaceuticals Operations, INC. | $26.37 | 2025 | Neffy |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $21.29 | 2024 | Ycanth |
| Cranial Technologies, INC | $20.68 | 2024 | Doc Band |
| Corium, LLC | $19.98 | 2022 | |
| Sobi, INC | $19.13 | 2023 | |
| Alexion Pharmaceuticals, INC. | $16.44 | 2025 | Koselugo |
| Sanofi Pasteur INC. | $16.41 | 2023 | |
| Phadia US INC. | $16.04 | 2021 | |
| Shire North American Group INC | $15.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Francis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.